Συγγραφείς:
Tsivgoulis, G.
Fragkou, P.C.
Lachanis, S.
Palaiodimou, L.
Lambadiari, V.
Papathanasiou, M.
Sfikakis, P.P.
Voumvourakis, K.I.
Tsiodras, S.
Λέξεις-κλειδιά:
azithromycin; corticosteroid; hydroxychloroquine; nuclear magnetic resonance imaging agent, adult; aged; anosmia; case control study; clinical article; contrast enhancement; controlled clinical trial; controlled study; coronavirus disease 2019; corticosteroid therapy; disease severity; female; hospital based case control study; human; hyposmia; Letter; male; middle aged; nuclear magnetic resonance imaging; odor recognition test; olfactory bulb; olfactory mucosa; pilot study; priority journal; prospective study; sino-nasal outcome test-22; young adult
